SOX12 was significantly upregulated in CRC tissues compared with adjacent normal tissues and was expressed at higher levels in CRC tissues from patients with metastases (65 of 120) than in those from nonmetastatic patients (55 of 120, Fig. 1c). The gene discussed is SOX12; the disease is colorectal carcinoma.